Simulations Plus

Simulations Plus Enterprise Value

The Enterprise Value (EV) of Simulations Plus (SLP) as of Sep 27, 2026 is 215.25 M USD. In the previous year, Enterprise Value (EV) was 227.35 M USD — a change of -5.32% (lower).

Enterprise Value

215.25 MUSD

YoY

-5.32%

Last updated:

Enterprise Value (EV) of Simulations Plus is 2026 215.25 M USD. Enterprise Value (EV) of Simulations Plus was 2025 227.35 M USD. It decreases by -5.32% lower compared to the previous year.

The Simulations Plus Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2018
238.20 M USD
Jan 1, 2019
236.17 M USD
Jan 1, 2020
131.59 M USD
Jan 1, 2021
124.00 M USD
Jan 1, 2022
119.37 M USD
Jan 1, 2023
132.14 M USD
Jan 1, 2024
227.35 M USD
Jan 1, 2025
215.25 M USD
The Simulations Plus Enterprise Value history
YEAREnterprise ValueYoY
215.25 MUSD-5.32%
227.35 MUSD+72.05%
132.14 MUSD+10.70%
119.37 MUSD-3.73%
124.00 MUSD-5.77%
131.59 MUSD-44.28%
236.17 MUSD-0.85%
238.20 MUSD-1.32%
241.39 MUSD+0.76%
239.57 MUSD+0.22%
239.05 MUSD+0.03%
238.99 MUSD—
Access this data via the Eulerpool API

Simulations Plus Stock analysis

What does Simulations Plus do? Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health. The translation of the text is: "Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health." Simulations Plus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Simulations Plus stock

Enterprise Value (EV) of Simulations Plus is 215.25 M USD in 2026.

Enterprise Value (EV) of Simulations Plus changed from 227.35 M USD to 215.25 M USD, representing a -5.32% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Simulations Plus since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s USD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' USD varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Simulations Plus with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Simulations Plus

All Key Metrics — Simulations Plus